Advertisement

Drugs & Therapy Perspectives

, Volume 34, Issue 12, pp 596–596 | Cite as

Correction to: Amphetamine extended-release oral suspension (Adzenys ER™) and orally disintegrating tablets (Adzenys XR-ODT®) in attention-deficit hyperactivity disorder: a profile of their use

  • Katherine A. Lyseng-Williamson
Correction
  • 518 Downloads

Correction to: Drugs & Therapy Perspectives (2018) 34(9):411–419  https://doi.org/10.1007/s40267-018-0539-6

Page 416, column 2, from the beginning of the sentence on the last line to the end of the sentence on page 417, column 1, lines 1–4: the following text, which previously read:

“A 2-h duration of treatment was indicated by the significant (p < 0.05) improvements from baseline in Conners’ Adult ADHD Rating Scale Short-Version Self-Report scores at 4- and 12-h after administrations.”

Should read:

“A 12-h duration of treatment was indicated by the significant (p < 0.05) improvements from baseline in Conners’ Adult ADHD Rating Scale Short-Version Self-Report scores at 4- and 12-h after administration.”

Copyright information

© Springer Nature Switzerland AG 2018

Authors and Affiliations

  1. 1.SpringerAucklandNew Zealand

Personalised recommendations